https://www.selleckchem.com/products/ws6.html
OBJECTIVES This study sought to assess 2-year clinical outcome following percutaneous coronary intervention (PCI) with thin-strut new-generation drug-eluting stents (DES) in patients treated in proximal left anterior descending artery (P-LAD) versus non-P-LAD lesions. BACKGROUND In current revascularization guidelines, P-LAD coronary artery stenosis is discussed separately, mainly because of a higher adverse event risk and benefits of bypass surgery. METHODS The study included 6,037 patients without previous bypass surgery or left main stem
Like
Comment
Share
